Login to Your Account

Karo Bio Seeking SEK280M In Discounted Rights Issue

By Cormac Sheridan

Wednesday, October 5, 2005
Karo Bio AB is seeking SEK280 million (US$35.9 million) in a discounted rights issue to fund its switch from early stage discovery to clinical development. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription